Live Chat
Call Now: (312) 600-0000
Get a FREE Case Review
Leading Lawyers logo
Super Lawyers logo
American Association for Justice
WILG logo
Illinois Trial Lawyers Association logo
Avvo Rating logo
Workers' Compensation Lawyers Association logo

Dangers of Mass Production of Pharmaceuticals and Medical Devices

Written by Ankin Law Office

Bausch and Lomb recently recalled approximately 36,000 bottles of eyes drops after they were found to contain printer ink. The recalled eye drops were not sold directly to consumers, but rather, they were provided to medical professionals who have been warned of the risks associated with these bottles. Nonetheless, the recall has caused many consumers to wonder: Just how does printer ink end up in bottles of eye drops anyway?

Although Bausch and Lomb has not provided the public with any information about how the printer ink made its way into the bottles of eye drops, the recall highlights the risks associated with the mass production of pharmaceuticals and medical devices. As a product grows in popularity, efficacy, and marketability, its manufacturer expands production nationally and even globally. Unfortunately, in some cases, mass production and increased demand results in inadequate quality control practices.

Inadequate Medical Testing

Similarly, when the Stryker Othropedics announced that it was recalling its Rejuvenate and ABG II Modular-Neck Hip Implant Systems last year, some critics questioned whether the problems associated with the recalled Stryker hip implant were the result of inadequate medical testing. Like other metal-on-metal hip implants, including the DePuy ASR, which was recalled in 2010, the Stryker ABG II received fast-track FDA approval through the 510(k) approval process, which allows manufacturers to avoid conducting long-term safety studies of new devices as long as they are “substantially similar” to existing devices. Because Stryker claimed that the Stryker Rejuvenate Modular Hip was “similar” to other existing hip implants, long-term safety studies of the metal hip were not conducted.

Moreover, recent evidence has come to light in a lawsuit against Johnson & Johnson for its defective ASR hip implant system indicating that company officials may have known that the hip implant was more dangerous than they let on to the public.

As we reported, the Stryker hip implants and DePuy hip implants were recalled due to risks of corrosion and fretting which can damage or injure surrounding tissues that may result in severe pain, inflammation, metal poisoning, tissue death, bone damage, pseudotumers, gait issues, and other serious problems. Patients may require a subsequent corrective surgery to remove and replace the recalled hip product.

What Does This Mean for Consumers?

Patient and consumers are reminded that it is important to be their own best advocate. If you suspect that something is unsafe or seems amiss regarding a pharmaceutical or medical device, you should notify your doctor immediately. Similarly, consumers should remain abreast of safety recalls provided by the U.S. Consumer Product Safety Commission.

If you suspect that you have been injured by an unsafe pharmaceutical or defective medical device, you should consult with an experienced product liability attorney like the Chicago unsafe pharmaceutical attorneys at Ankin Law Office, LLC, as soon as possible. Contact our office at (312) 600-0000 to schedule a free consultation with one of our Chicago consumer safety attorneys.

Categories: Product Liability